Target intelligence / Profile preview

Inflammatory and oxidative processes

Molecular classification
Other, Biological process
01

Overview

Inflammatory and oxidative processes describe the interconnected physiological and pathological mechanisms involving immune activation and the production of reactive oxygen species (ROS). Inflammation is a protective response to stimuli such as pathogens or tissue injury, but when chronic, it leads to tissue damage through the release of pro-inflammatory cytokines (Source: NIH, StatPearls, "Inflammation"). Oxidative stress occurs when the production of ROS exceeds the capacity of antioxidant systems, leading to oxidative damage to cellular components (Source: PubMed, PMID: 23626316). These two processes are mutually reinforcing; for instance, ROS can activate the NF-κB signaling pathway, which in turn promotes the expression of inflammatory genes (Source: PubMed, PMID: 19892413). While not a single molecular target, these processes are central to the pathology of cardiovascular diseases, neurodegeneration, and cancer (Source: Nature Reviews Drug Discovery). Therapeutic strategies often involve targeting specific nodes within these processes, such as inhibiting cyclooxygenase enzymes or activating the Nrf2-mediated antioxidant response (Source: PubChem). However, broad modulation of these pathways carries risks, including impaired immune surveillance and interference with essential redox-dependent signaling (Source: PubMed, PMID: 28412214).

Other names
Oxidative stress and inflammationRedox-inflammatory signalingInflamm-agingChronic low-grade inflammation
02

Mechanism of action

Modulation of pro-inflammatory signaling pathways (e.g., NF-κB), inhibition of pro-oxidant enzymes (e.g., NADPH oxidase), and upregulation of antioxidant defenses via the Nrf2 pathway.

03

Biological functions

Immune responseRedox homeostasisSignal transductionCell deathApoptosis
04

Disease associations

Cardiovascular diseaseNeurodegenerative diseaseCancerDiabetes mellitusChronic obstructive pulmonary disease (COPD)Inflammation
05

Safety considerations

Gastrointestinal toxicityIncreased risk of infectionImpaired wound healingDisruption of physiological ROS signaling
06

Interacting drugs

Aspirin

5 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)Tumor necrosis factor-alpha (TNF-α)

Beyond the preview

Go deeper on Inflammatory and oxidative processes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inflammatory and oxidative processes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call